Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3818

1.

Gender Parity in Gainful Employment and Other Gender Trends in the Job Market for Recent Pathology Graduates.

Shyu I, Johnson KA, George MR, Gratzinger D, Brissette MD, Childs JM, Conran RM, Dixon LR, McCloskey CB, Prieto VG, Roberts CA, Rojiani AM, Timmons CF Jr, Hoffman RD.

Arch Pathol Lab Med. 2019 Dec 9. doi: 10.5858/arpa.2019-0354-CP. [Epub ahead of print]

PMID:
31816267
2.

Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.

Zhu G, Zhao M, Han Q, Tan Y, Sun YU, Bouvet M, Clary B, Singh SR, Ye J, Hoffman RM.

Anticancer Res. 2019 Dec;39(12):6463-6470. doi: 10.21873/anticanres.13860.

PMID:
31810910
3.

Pre-clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice.

Patel A, Clementelli CM, Jarocha D, Mosoyan G, Else C, Kintali M, Fong H, Tong J, Gordon R, Gillespie V, Keyzner A, Poncz M, Hoffman R, Iancu-Rubin C.

Transfusion. 2019 Dec;59(12):3698-3713. doi: 10.1111/trf.15546. Epub 2019 Nov 5.

PMID:
31802511
4.

A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.

Li Y, Higgs RE, Hoffman RW, Dow ER, Liu X, Petri M, Wallace DJ, Dörner T, Eastwood BJ, Miller BB, Liu Y.

PLoS One. 2019 Dec 2;14(12):e0225651. doi: 10.1371/journal.pone.0225651. eCollection 2019.

5.

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).

Mascarenhas J, Marcellino BK, Lu M, Kremyanskaya M, Fabris F, Sandy L, Mehrotra M, Houldsworth J, Najfeld V, El Jamal S, Petersen B, Moshier E, Hoffman R.

Leuk Res. 2019 Nov 16;88:106272. doi: 10.1016/j.leukres.2019.106272. [Epub ahead of print]

PMID:
31778911
6.

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.

Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.

Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.

7.

US Centers for Disease Control and Prevention's HEADS UP Branding and Evaluation Process.

Waltzman D, Hoffman R, Donnell Z, Bell E, Sarmiento K.

Health Educ J. 2019;78. doi: 10.1177/0017896919873931. Epub 2019 Sep 5.

PMID:
31768074
8.

The Dilemma of Treating Postdural Puncture Headache.

Hoffman RC, Riordan JA.

Anesth Analg. 2019 Nov 18. doi: 10.1213/ANE.0000000000004526. [Epub ahead of print] No abstract available.

PMID:
31764162
9.

Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia.

Hoffman RM, Balakasi K, Bardon AR, Siwale Z, Hubbard J, Kakwesa G, Haambokoma M, Kalua T, Pisa P, Moyo C, Dovel K, Xulu T, Sanne I, Fox M, Rosen S.

AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002435. [Epub ahead of print]

PMID:
31764076
10.

Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations.

Dang NC, Ardehali A, Bruckner BA, Parrino PE, Gillen DL, Hoffman RW, Spotnitz R, Cavoores S, Shorn IJ, Manson RJ, Spotnitz WD.

J Card Surg. 2019 Nov 25. doi: 10.1111/jocs.14376. [Epub ahead of print]

PMID:
31763732
11.

Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model.

Park JH, Han Q, Zhao M, Tan Y, Higuchi T, Yoon SN, Sugisawa N, Yamamoto J, Bouvet M, Clary B, Singh SR, Hoffman RM.

Tissue Cell. 2019 Dec;61:109-114. doi: 10.1016/j.tice.2019.09.006. Epub 2019 Sep 21.

PMID:
31759402
12.

Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study.

Seaman AT, Taylor KL, Davis K, Nepple KG, Lynch JH, Oberle AD, Hall IJ, Volk RJ, Reisinger HS, Hoffman RM.

PLoS One. 2019 Nov 20;14(11):e0225134. doi: 10.1371/journal.pone.0225134. eCollection 2019.

13.

Influence of Long-Term Furosemide Use on Bone Mineral Content, Bone Metabolism Markers, and Water Weight Loss in Horses.

Pritchard A, Spooner H, Hoffman R.

J Equine Vet Sci. 2019 Nov;82:102800. doi: 10.1016/j.jevs.2019.102800. Epub 2019 Oct 1.

PMID:
31732111
14.

Enhanced electro-optic beam deflection of relaxor ferroelectric KTN crystals by electric-field-induced high permittivity.

Chen CJ, Chao JH, Lee YG, Shang A, Liu R, Yin S, Hoffman RC.

Opt Lett. 2019 Nov 15;44(22):5557-5560. doi: 10.1364/OL.44.005557.

PMID:
31730107
15.

'Blood pressure can kill you tomorrow, but HIV gives you time': illness perceptions and treatment experiences among Malawian individuals living with HIV and hypertension.

Hing M, Hoffman RM, Seleman J, Chibwana F, Kahn D, Moucheraud C.

Health Policy Plan. 2019 Nov 1;34(Supplement_2):ii36-ii44. doi: 10.1093/heapol/czz112.

PMID:
31723966
16.

Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms.

Sapre M, Tremblay D, Wilck E, James A, Leiter A, Coltoff A, Koshy AG, Kremyanskaya M, Hoffman R, Mascarenhas JO, Gallagher EJ.

Sci Rep. 2019 Nov 12;9(1):16609. doi: 10.1038/s41598-019-53056-x.

17.

Response to Letter to the Editor Re: "What Should OEM Physicians Know About Ammonium Bifluoride?"

Downs JW, Hoffman RM, Cumpston KL, Rose SR.

J Occup Environ Med. 2019 Nov 8. doi: 10.1097/JOM.0000000000001764. [Epub ahead of print] No abstract available.

PMID:
31714376
18.

Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis.

Tremblay D, King A, Li L, Moshier E, Coltoff A, Koshy A, Kremyanskaya M, Hoffman R, Mauro MJ, Rampal RK, Mascarenhas J.

Leuk Lymphoma. 2019 Nov 12:1-8. doi: 10.1080/10428194.2019.1688323. [Epub ahead of print]

PMID:
31711337
19.

The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.

Higuchi T, Sugisawa N, Yamamoto J, Oshiro H, Han Q, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Tan Y, Kuchipudi S, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Cancer Chemother Pharmacol. 2019 Nov 8. doi: 10.1007/s00280-019-03986-0. [Epub ahead of print]

PMID:
31705268
20.

Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.

Zhu G, Zhao M, Han Q, Tan Y, Sun YU, Bouvet M, Singh SR, Ye J, Hoffman RM.

Anticancer Res. 2019 Nov;39(11):5999-6005. doi: 10.21873/anticanres.13805.

PMID:
31704825

Supplemental Content

Loading ...
Support Center